Wellness Index Report, an independent wellness ratings and education platform, has published a new Inside the Index feature spotlighting Nefense, a company recognized as a leader in nasal health innovation. The report examines the growing consumer interest in nasal health, respiratory hygiene, and drug-free alternatives to traditional care.
The feature reviews emerging research on hypochlorous acid (HOCl), noting its antimicrobial and anti-inflammatory properties and potential uses across respiratory health and infection control. Nefense offers doctor-recommended, ENT-approved, family-friendly HOCl and xylitol-based nasal solutions as a drug-free alternative to over-the-counter sprays. These products are formulated under the direction of Dr. Richard Downs, DDS.
According to the Wellness Index Report, Nefense is helping redefine modern nasal wellness through innovative products that cater to a market increasingly seeking non-pharmaceutical options. The full announcement, including downloadable images and bios, is available here.
Wellness Index Report, founded by Lindsay O'Neill-O’Keefe, is an independent health and wellness education platform dedicated to helping consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring. Through its Inside the Index editorial series, the organization highlights companies, practitioners, and technologies shaping the future of wellness and longevity.
The recognition of Nefense underscores a broader shift toward drug-free, scientifically backed approaches to nasal care, with implications for both individual health and public respiratory hygiene. As consumers become more proactive about wellness, products like those from Nefense may play a key role in reducing reliance on medicated sprays and supporting overall respiratory health.
